District Of Columbia § 48-902.04 - Schedule I enumerated.

Full text of District Of Columbia D.C. Code § 48-902.04 — Schedule I enumerated., with citation guidance and answers to common questions.

§ 48-902.04. Schedule I enumerated.

48-902.04

The controlled substances listed in this section are included in Schedule I, unless and until removed therefrom pursuant to :

(a)
(1)

Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

(A)

Acetylmethadol;

(B)

Allylprodine;

(C)

Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alphaacetylmethadol, levomethadyl, accetate, or LAAM);

(D)

Alphameprodine;

(E)

Alphamethadol;

(F)

Benzethidine;

(G)

Betacetylmethadol;

(H)

Betameprodine;

(I)

Betamethadol;

(J)

Betaprodine;

(K)

Clonitazene;

(L)

Dextromoramide;

(M)

Diampromide;

(N)

Diethylthiambutene;

(O)

Difenoxin;

(P)

Dimenoxadol;

(Q)

Dimepheptanol;

(R)

Dimethylthiambutene;

(S)

Dioxaphetylbutyrate;

(T)

Dipipanone;

(U)

Ethylmethylthiambutene;

(V)

Etonitazene;

(W)

Etoxeridine;

(X)

Furethidine;

(Y)

Hydroxypethidine;

(Z)

Ketobemidone;

(AA)

Levomoramide;

(BB)

Levophenacylmorphan;

(CC)

Morpheridine;

(DD)

Noracymethadol;

(EE)

Norlevorphanol;

(FF)

Normethadone;

(GG)

Norpipanone;

(HH)

Phenadoxone;

(II)

Phenampromide;

(JJ)

Phenomorphan;

(KK)

Phenoperidine;

(LL)

Piritramide;

(MM)

Proheptazine;

(NN)

Properidine;

(OO)

Propiram;

(PP)

Racemoramide;

(QQ)

Thiophene;

(RR)

Trimeperidine;

(SS)

Acetyl-Alpha-Methylfentanyl;

(TT)

Alphe-methylfentanyl;

(UU)

Alpha-Methylthiofentanyl;

(VV)

Beta-hydroxyfentanyl;

(WW)

Beta-hydroxy-3-Methylfentanyl;

(XX)

3-Methylfentanyl;

(YY)

3-Methylthiofentanyl;

(ZZ)

MPPP;

(AAA)

Para-flurofentanyl;

(BBB)

PEPAP;

(CCC)

Thiofentanyl; and

(DDD)

Tilidine;

(2)

Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:

(A)

Acetorphine;

(B)

Acetyldihydrocodeine;

(C)

Benzylmorphine;

(D)

Codeine methylbromide;

(E)

Codeine-N-Oxide;

(F)

Cyprenorphine;

(G)

Desomorphine;

(H)

Dihydromorphine;

(I)

Drotepanol;

(J)

Etorphine (except hydrochloride salt);

(K)

Diacetylated morphine (heroin);

(L)

Hydromorphinol;

(M)

Methyldesorphine;

(N)

Methyldihydromorphine;

(O)

Morphine methylbromide;

(P)

Morphine methylsulfonate;

(Q)

Morphine-N-Oxide;

(R)

Myrophine;

(S)

Nicocodeine;

(T)

Nicomorphine;

(U)

Normorphine;

(V)

Pholcodine; and

(W)

Thebacon;

(3)

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, its salts, isomers and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term “isomer” includes the optical, position, and geometric isomers):

(A)

4-bromo-2, 5-dimethoxyamphetamine;

(B)

2, 5 dimethoxyamphetamine;

(C)

4-methoxyamphetamine;

(D)

5-methoxy-3, 4-methylenedioxy amphetamine;

(E)

4-methyl-2,5-dimethoxyamphetamine;

(F)

3,4-methylenedioxyamphetamine [MDA];

(G)

3, 4, 5-trimethoxy amphetamine;

(H)

Bufotenine;

(I)

Diethyltryptamine;

(J)

Dimethyltryptamine;

(K)

Ethylamide analog of phencyclidine, PCE;

(L)

Ibogaine;

(M)

Lysergic acid diethylamide;

(N)

Mescaline;

(O)

Peyote;

(P)

N-ethyl-3-piperidyl benzilate;

(Q)

N-methyl-3-piperidyl benzilate;

(R)

Psilocybin;

(S)

Psilocyn;

(T)

Pyrrolidine analog of phencyclidine, PCPY;

(U)

Thiophene analog of phencyclidine;

(V)

Repealed;

(W)

Parahexyl;

(X)

4-bromo-2,5-dimethoxyphenethylamine;

(Y)

3,4-methylenedioxymethamphetamine [MDMA];

(Z)

Alpha-methyltryptamine (other name: AMT);

(AA)

5-methoxy-N,N-diisopropyltryptamine (other name: 5- MeO-DIPT);

(BB)

2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7);

(CC)

2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);

(DD)

2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);

(EE)

2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);

(FF)

2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);

(GG)

2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);

(HH)

2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C- T-4);

(II)

2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);

(JJ)

2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N); and

(KK)

2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);

(4)

Unless specifically excepted or unless listed in another schedule, any material, compound, or mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(A)

Mecloqualone;

(B)

Methaqualone; and

(C)

Gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);

(5)

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including their analogues or derivatives and its salts, isomers, and salts of isomers:

(A)

Fenethyline;

(B)

N-ethylamphetamine;

(C)

Cathinone;

(D)

N-Benzylpiperazine (some other names: BZP, 1- benzylpiperazine);

(E)

Methcathinone (Some other names: 2-(methylamino)- propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1- one; alpha- -methylaminopropiophenone; monomethylpropion; ephedrone; — methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers, as well as synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to methcathinone;

(F)

4-methyl-N-methylcathinone (other name: mephedrone);

(G)

3,4-methylenedioxypyrovalerone (other name: MDPV); and

(H)

3,4-methylenedioxy-N-methylcathinone (other name: methylone).

Annotations

Source: official District Of Columbia text · Last verified 2026-08-27

Related District Of Columbia Legal Topics

Frequently Asked Questions About District Of Columbia § 48-902.04

What does D.C. Code § 48-902.04 cover?

Section 48-902.04 ("Schedule I enumerated.") is part of the D.C. Code, the codified statutory law of District Of Columbia. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.

How do I cite District Of Columbia § 48-902.04?

A common citation format is "D.C. Code § 48-902.04" (District Of Columbia). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.

Is this the official text of District Of Columbia law?

No. This page is for research and education and may not include the most recent amendments. For official current law, check the District Of Columbia official source linked on this page or consult a licensed District Of Columbia attorney.

How does District Of Columbia § 48-902.04 apply to my situation?

Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in District Of Columbia can advise on how this section applies to you. Contact your state or local bar association for a referral.

Sources & Verification

Not legal advice. Verify against the official source and consult a licensed attorney in District Of Columbia.